메뉴 건너뛰기




Volumn 37, Issue 10, 2003, Pages 1434-1437

Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol

Author keywords

Dystonic reaction; Haloperidol; Oculogyric crisis

Indexed keywords

BENZATROPINE; HALOPERIDOL;

EID: 0141669305     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C389     Document Type: Article
Times cited : (20)

References (32)
  • 3
    • 0021327806 scopus 로고
    • Neuroleptics as causes of oculogyric crises
    • Dorevitch A. Neuroleptics as causes of oculogyric crises. Arch Neurol 1984;41:15-6.
    • (1984) Arch Neurol , vol.41 , pp. 15-16
    • Dorevitch, A.1
  • 4
    • 0025236537 scopus 로고
    • Dystonia - A potential psychiatric pitfall
    • Owens DGC. Dystonia - a potential psychiatric pitfall. Br J Psychiatry 1990;156:620-34.
    • (1990) Br J Psychiatry , vol.156 , pp. 620-634
    • Owens, D.G.C.1
  • 5
    • 0016812228 scopus 로고
    • Drug-induced dystonia
    • Swett C. Drug-induced dystonia. Am J Psychiatry 1975;132:532-4.
    • (1975) Am J Psychiatry , vol.132 , pp. 532-534
    • Swett, C.1
  • 7
    • 0003174188 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with schizophrenia
    • American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry 1997;154(suppl 4):1-63.
    • (1997) Am J Psychiatry , vol.154 , Issue.SUPPL. 4 , pp. 1-63
  • 8
    • 0022445363 scopus 로고
    • Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: A prospective study
    • Sramek JJ, Simpson GM, Morrison RL, Heiser JF. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study. J Clin Psychiatry 1986;47:305-9.
    • (1986) J Clin Psychiatry , vol.47 , pp. 305-309
    • Sramek, J.J.1    Simpson, G.M.2    Morrison, R.L.3    Heiser, J.F.4
  • 9
    • 0029930910 scopus 로고    scopus 로고
    • Circadian pattern of acute neuroleptic-induced dystonic reactions
    • Mazurek MF, Rosebush PI. Circadian pattern of acute neuroleptic-induced dystonic reactions. Am J Psychiatry 1996;153:708-10.
    • (1996) Am J Psychiatry , vol.153 , pp. 708-710
    • Mazurek, M.F.1    Rosebush, P.I.2
  • 10
    • 0009676668 scopus 로고
    • Neuroleptic-induced acute dystonia
    • Lang AE, Weiner WJ, eds. New York: Futura Press
    • Casey DE. Neuroleptic-induced acute dystonia. In: Lang AE, Weiner WJ, eds. Drug-induced movement disorders. New York: Futura Press, 1991:21-40.
    • (1991) Drug-induced Movement Disorders , pp. 21-40
    • Casey, D.E.1
  • 11
    • 0032939740 scopus 로고    scopus 로고
    • Acute laryngeal dystonia related to neuroleptic agents
    • Fines RE, Brady WJ Jr, Martin ML. Acute laryngeal dystonia related to neuroleptic agents. Am J Emerg Med 1999;17:319-20.
    • (1999) Am J Emerg Med , vol.17 , pp. 319-320
    • Fines, R.E.1    Brady W.J., Jr.2    Martin, M.L.3
  • 12
    • 0025268175 scopus 로고
    • Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment
    • World Health Organization Heads of Centres Collaborating in WHO coordinated studies on biological aspects of mental illness [letter]. Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. Br J Psychiatry 1990;156:412.
    • (1990) Br J Psychiatry , vol.156 , pp. 412
  • 13
    • 0026410773 scopus 로고
    • Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose
    • McEvoy JP, Hogarty GE, Steingard S. Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. Arch Gen Psychiatry 1991;48:739-45.
    • (1991) Arch Gen Psychiatry , vol.48 , pp. 739-745
    • McEvoy, J.P.1    Hogarty, G.E.2    Steingard, S.3
  • 14
    • 0016491711 scopus 로고
    • Therapeutic reversal with benztropine in schizophrenics
    • Singh MM, Kay SR. Therapeutic reversal with benztropine in schizophrenics. J Nerv Ment Dis 1973;169:258-66.
    • (1973) J Nerv Ment Dis , vol.169 , pp. 258-266
    • Singh, M.M.1    Kay, S.R.2
  • 16
    • 0027439488 scopus 로고
    • Tardive and chronically recurrent oculogyric crisis
    • Sachdev P. Tardive and chronically recurrent oculogyric crisis. Move Disord 1993;8:93-7.
    • (1993) Move Disord , vol.8 , pp. 93-97
    • Sachdev, P.1
  • 17
  • 18
    • 0016138354 scopus 로고
    • Antischizophrenic drugs and brain cholinergic receptors
    • Snyder S, Greenberg D, Yamamura H. Antischizophrenic drugs and brain cholinergic receptors. Arch Gen Psychiatry 1974;31:58-61.
    • (1974) Arch Gen Psychiatry , vol.31 , pp. 58-61
    • Snyder, S.1    Greenberg, D.2    Yamamura, H.3
  • 19
    • 0021327806 scopus 로고
    • Neuroleptics as causes of oculogyric crisis
    • Dorevitch A. Neuroleptics as causes of oculogyric crisis. Arch Neurol 1984;41:15-6.
    • (1984) Arch Neurol , vol.41 , pp. 15-16
    • Dorevitch, A.1
  • 20
    • 0033392246 scopus 로고    scopus 로고
    • Pharmacokinetics of haloperidol: An update
    • Kudo S, Ishizaki T. Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet 1999;37:435-56.
    • (1999) Clin Pharmacokinet , vol.37 , pp. 435-456
    • Kudo, S.1    Ishizaki, T.2
  • 22
    • 0000340348 scopus 로고
    • Parkinsonism-inducing neurotoxin N-methyl-1-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
    • Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH. Parkinsonism-inducing neurotoxin N-methyl-1-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 1985;82:2173-7.
    • (1985) Proc Natl Acad Sci USA , vol.82 , pp. 2173-2177
    • Javitch, J.A.1    D'Amato, R.J.2    Strittmatter, S.M.3    Snyder, S.H.4
  • 24
    • 0030722966 scopus 로고    scopus 로고
    • Metabolism of haloperidol to pyridium species in patients receiving high doses intravenously: Is HPTP an intermediate?
    • Avent KM, Riker RR, Fraser GL, van der Schyf CJ, Usuki E, Pond SM. Metabolism of haloperidol to pyridium species in patients receiving high doses intravenously: is HPTP an intermediate? Life Sci 1997;61:2383-90.
    • (1997) Life Sci , vol.61 , pp. 2383-2390
    • Avent, K.M.1    Riker, R.R.2    Fraser, G.L.3    Van der Schyf, C.J.4    Usuki, E.5    Pond, S.M.6
  • 25
    • 0028358360 scopus 로고
    • Metabolism of haloperidol: Clinical implications and unanswered questions
    • Tsang MW, Shader RI, Greenblatt DJ. Metabolism of haloperidol: clinical implications and unanswered questions. J Clin Psychopharmacol 1994;14:159-62.
    • (1994) J Clin Psychopharmacol , vol.14 , pp. 159-162
    • Tsang, M.W.1    Shader, R.I.2    Greenblatt, D.J.3
  • 26
    • 0031963869 scopus 로고    scopus 로고
    • Haloperidol plasma levels and dose optimization
    • Coryell W, Miller DD, Perry PJ. Haloperidol plasma levels and dose optimization. Am J Psychiatry 1998;155:48-53.
    • (1998) Am J Psychiatry , vol.155 , pp. 48-53
    • Coryell, W.1    Miller, D.D.2    Perry, P.J.3
  • 29
    • 0026718710 scopus 로고
    • 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
    • 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 1992;49:538-44.
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 538-544
    • Farde, L.1    Nordstrom, A.L.2    Wiesel, F.A.3    Pauli, S.4    Halldin, C.5    Sedvall, G.6
  • 31
    • 0022922096 scopus 로고
    • Plasma haloperidol levels drawn at neuroleptic threshold doses: A pilot study
    • McEvoy JP, Stiller RL, Farr R. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study. J Clin Psychopharmacol 1986;6:133-8.
    • (1986) J Clin Psychopharmacol , vol.6 , pp. 133-138
    • McEvoy, J.P.1    Stiller, R.L.2    Farr, R.3
  • 32
    • 0026410773 scopus 로고
    • Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose
    • McEvoy JP, Hogarty GE, Steingard S. Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. Arch Gen Psychiatry 1991;48:739-45.
    • (1991) Arch Gen Psychiatry , vol.48 , pp. 739-745
    • McEvoy, J.P.1    Hogarty, G.E.2    Steingard, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.